Kerala Health Minister's Meeting Sparks Debate Over SMA Drug Distribution
Photos of Kerala Health Minister K Muraleedharan meeting a pharmaceutical company amid a controversy over low-cost Indian-made SMA medicines have sparked debate. The minister denied any link between the meeting and government decisions, emphasizing expert committee endorsements. Opposition leaders, including Pinarayi Vijayan and CPI(M) members, criticized the drug distribution, citing concerns over medicines labeled for clinical trials. Hospital authorities and experts defended the generic drug's approval and safety, noting the decision began under the previous government to ensure supply and affordability.
First-hand measurement across 9 sources
We measured how 9 outlets covered this story. Coverage leans balanced overall (Left 2%, Centre 77%, Right 21%). Overall sentiment is neutral (45/100). Lens Score 71/100.
Outlets measured: deccanherald, theprint, news18, thehindu, indiatoday, theprint, thehindu, hindustantimes, and 1 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 9 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (28–55/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 20 Oct, 10:45 am. Other outlets followed.